Sign in

CIK 0001815903

  • Emerging growth company

Petros Pharmaceuticals, Inc.

Sign in to watch
Ticker
PTPI
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851410058
Phone
+1 973-242-0005
Business address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-12-22 SHULMAN JOHN D Director Purchase +145,773 $3.43 $500K 5,703,544
2021-12-22 SHULMAN JOHN D Director Purchase · Warrant +109,329 109,329
2021-11-29 SHULMAN JOHN D Director Purchase +500,000 $3.00 $1.5M 5,557,771
2021-11-29 SHULMAN JOHN D Director Purchase · Warrant +375,000 375,000
2021-10-18 SHULMAN JOHN D Director Purchase +1,661,807 $1.72 $2.8M 5,057,771
2021-10-18 SHULMAN JOHN D Director Purchase · Warrant +1,661,807 1,661,807
2021-04-08 SHULMAN JOHN D Director Grant or award · Stock Option (right to buy) +50,000 50,000
2020-12-01 SHULMAN JOHN D Director Grant or award +3,395,964 3,395,964
2020-12-01 SHULMAN JOHN D Director Grant or award +3,382,416 3,382,416

Page 1 of 1 · 9 trades